Cargando…
Recent Advances in Locoregional Therapy of Hepatocellular Carcinoma
SIMPLE SUMMARY: Hepatocellular carcinoma (HCC) is the fifth most common cancer worldwide and the second most common oncological reason for death. Liver resection and transplantation are considered the only potential cure options for HCC. The majority of patients, however, are late in presentation an...
Autores principales: | Podlasek, Anna, Abdulla, Maheeba, Broering, Dieter, Bzeizi, Khalid |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10341377/ https://www.ncbi.nlm.nih.gov/pubmed/37444457 http://dx.doi.org/10.3390/cancers15133347 |
Ejemplares similares
-
Hepatocellular Carcinoma Recurrence and Mortality Rate Post Liver Transplantation: Meta-Analysis and Systematic Review of Real-World Evidence
por: Bzeizi, Khalid I., et al.
Publicado: (2022) -
Effect of COVID-19 on liver abnormalities: a systematic review and meta‐analysis
por: Bzeizi, Khalid, et al.
Publicado: (2021) -
Locoregional Therapy Approaches for Hepatocellular Carcinoma: Recent Advances and Management Strategies
por: Makary, Mina S., et al.
Publicado: (2020) -
A Review on Inflammatory Bowel Diseases: Recent Molecular Pathophysiology Advances
por: Abdulla, Maheeba, et al.
Publicado: (2022) -
Locoregional therapies for the treatment of locally advanced hepatocellular carcinoma
por: da Motta-Leal-Filho, Joaquim Maurício
Publicado: (2021)